» Articles » PMID: 25078863

Increased Expression of Prostasin Contributes to Early-onset Severe Preeclampsia Through Inhibiting Trophoblast Invasion

Overview
Journal J Perinatol
Date 2014 Aug 1
PMID 25078863
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the potential role of prostasin, as an invasion suppressor, in the process of trophoblast invasion in preeclampsia.

Study Design: This case-control study included 19 early-onset severe preeclampsia (⩽ 34 weeks), 20 late-onset severe preeclampsia (>34 weeks) and 20 normal term pregnant women. Immunohistochemistry was conducted to identify the cellular localization of prostasin, as well as the matrix metalloproteinase 2 (MMP2) and MMP9 in the placenta tissues. Enzyme-linked immunosorbent assay was performed to analyze the expression of these three proteins in placental homogenates. The effect of prostasin on the invasive and migratory ability of trophoblast cells was detected by transwell assays. We also examined the regulation of the prostasin antibody in the MMP2 and MMP9 secretion by HTR-8/SVneo cells via blocking the prostasin activity.

Result: This study demonstrated that the prostasin, MMP2 and MMP9 were all expressed in the placental syncytiotrophoblasts. Increased expression of prostasin was detected in cases with early-onset severe preeclampsia compared with the late-onset and control groups (P < 0.05), whereas the expression patterns of MMP2 and MMP9 in placental homogenates were opposite to that of prostasin (P < 0.05). Recombinant prostasin inhibited the invasion and migration of trophoblast cells, whereas prostasin antibody enhanced the MMP2 and MMP9 secretion in a dose- and time-dependent manner.

Conclusion: These findings suggest that prostasin may suppress the invasion process in preeclampsia by attenuating MMP2 and MMP9 secretion.

Citing Articles

PPARγ Regulates Triclosan Induced Placental Dysfunction.

Li J, Quan X, Zhang Y, Yu T, Lei S, Huang Z Cells. 2022; 11(1).

PMID: 35011648 PMC: 8750171. DOI: 10.3390/cells11010086.


Implications for preeclampsia: hypoxia-induced Notch promotes trophoblast migration.

Perlman B, Merriam A, Lemenze A, Zhao Q, Begum S, Nair M Reproduction. 2021; 161(6):681-696.

PMID: 33784241 PMC: 8403268. DOI: 10.1530/REP-20-0483.


Retinol-binding protein 4 regulates the biological functions and molecular mechanisms of JEG-3 cells.

Wang F, Cao G, Liu Q, Li X, Song M, Zhang Z Int J Clin Exp Pathol. 2020; 11(12):5877-5884.

PMID: 31949674 PMC: 6963068.


ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia.

Liu L, Zhuang X, Jiang M, Guan F, Fu Q, Lin J Cell Death Dis. 2017; 8(9):e3054.

PMID: 28933788 PMC: 5636970. DOI: 10.1038/cddis.2017.419.


Notch2 and Notch3 suppress the proliferation and mediate invasion of trophoblast cell lines.

Zhao W, Wu Z, Liu W, Lin J Biol Open. 2017; 6(8):1123-1129.

PMID: 28606936 PMC: 5576079. DOI: 10.1242/bio.025767.


References
1.
Ilekis J, Reddy U, Roberts J . Preeclampsia--a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci. 2007; 14(6):508-23. DOI: 10.1177/1933719107306232. View

2.
von Dadelszen P, Magee L, Roberts J . Subclassification of preeclampsia. Hypertens Pregnancy. 2003; 22(2):143-8. DOI: 10.1081/PRG-120021060. View

3.
Roth I, Fisher S . IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol. 1999; 205(1):194-204. DOI: 10.1006/dbio.1998.9122. View

4.
Goldman-Wohl D, Yagel S . Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol. 2002; 187(1-2):233-8. DOI: 10.1016/s0303-7207(01)00687-6. View

5.
Roberts J, Taylor R, Musci T, Rodgers G, Hubel C, McLaughlin M . Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989; 161(5):1200-4. DOI: 10.1016/0002-9378(89)90665-0. View